The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have launched a call for evidence to evaluate the impact of resources developed under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
The two organisations are seeking feedback from a broad range of stakeholders. These include developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
What the survey is intended to establish
According to the MHRA and NICE, the survey forms part of the programme's Phase 1 evaluation and is intended to assess how the resources have been received and used across the sector. The organisations said they are particularly interested in whether the materials have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were created to support the safe development, regulation, evaluation and adoption of digital mental health technologies, a category that includes mental health apps and other digital tools.
Responses will be used to determine whether the Phase 1 outputs have achieved their intended objectives, and to inform the future direction of Phase 2 of the DMHT programme.
The MHRA and NICE encouraged stakeholders to take part whether they have engaged with the existing resources extensively, minimally or not at all. They said the feedback would help identify strengths, highlight areas for improvement and shape subsequent work aimed at improving the safety and effectiveness of digital mental health technologies.